Picture of Organovo Holdings logo

ONVO Organovo Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Organovo Holdings, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-26.6-18.7-16.8-11.4-17.3
Depreciation
Non-Cash Items5.133.685.582.262.25
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.15-0.998-2.110.5972.31
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-20.4-14.9-13.3-8.45-12.4
Capital Expenditures-0.0790-0.405-0.409-0.396
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0030.7470.0120-0.57
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.0760.747-0.393-0.409-0.966
Financing Cash Flow Items-0.223-0.061-0.004-0.0460
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities13.24.9323.80.2050
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-7.3-9.210.1-8.66-13.4